Image courtesy by QUE.com Understanding Frontier AI in Cybersecurity As the capabilities of artificial intelligence (AI) ...

Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ligand-conjugated vectors, today announces it will deliver two poster presentations at ...

Artificial intelligence may still be on an upward trajectory, but 2026 is shaping up to be a critical turning point. In this ...

Coca-Cola (NYSE: KO) is one of the most famous long-term investment stories in history, starting with Warren Buffett.

B for Kelonia adds a credible in vivo CAR-T platform aimed at multiple myeloma, with a one-time IV delivery and no ...

This week, PharmTech took a look at the shift toward proactive, data-driven contamination control, the adoption of advanced material science to solve manufacturing hurdles, and an ...

In recent years, artificial intelligence has become more accessible than ever before. Powerful libraries, automated platforms ...

In a collaboration with Nvidia and Samsung, IBM said it has demonstrated a content-aware storage (CAS) system that can hold a ...

Eli Lilly will acquire Kelonia Therapeutics for up to $7bn, securing its lentiviral-based in vivo CAR-T platform and oncology pipeline. The move follows Lilly’s $2.4bn purchase of Orna Therapeutics, ...

Circle clarifies it freezes USDC only under legal compulsion after the $285M Drift exploit, urging Congress to pass the ...

At MWC 2026, Huawei released its AIDP. This platform integrates a knowledge base, KV cache acceleration, and a memory bank, and uses the Unified Cache Manager (UCM) to manage and schedule inference ...

Sister companies aim to strengthen collaborations with biotech and pharmaceutical companies across South Korea and Asia by offering over two decades of expertise in biosafety and quality control ...